Gene · 5916
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Tripartite fusion gene: a novel discovery in the pathogenesis and drug resistance of atypical acute promyelocytic leukemia]. | Zhonghua Yi Xue Za Zhi | 2025 | 41255004 | PubTator, text mining | PubMed |
| Linoleic Acid Potentiates Response to Chemotherapy in Biliary Tract Cancer Through RARγ Activation. | FASEB J | 2025 | 41229376 | PubTator, text mining | PubMed |
| The Next Generation of Skin Care: Transforming Retinoid Therapeutics. | Cells | 2025 | 41227299 | PubTator, text mining | PubMed |
| [Clinical characteristics and genotype analysis of two rare subtypes of acute myeloid leukemia]. | Zhonghua Yi Xue Za Zhi | 2025 | 41218897 | PubTator, text mining | PubMed |
| Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice. | Front Pharmacol | 2025 | 41104340 | PubTator, text mining | PubMed |
| DeepEPI: CNN-transformer-based model for extracting TF interactions through predicting enhancer-promoter interactions. | Bioinform Adv | 2025 | 41031058 | PubTator, text mining | PubMed |
| A Narrative Review of Phase II and III Clinical Trials for the Pharmacological Treatment of Fibrodysplasia Ossificans Progressiva (FOP): Efficacy, Safety, and Challenges in Treatment Strategies. | Drug Des Devel Ther | 2025 | 41017808 | PubTator, text mining | PubMed |
| Inhibition of lactylation by LRP1 expression increases the risk of intervertebral disc degeneration: A multi-omics summary-based Mendelian randomization analysis. | Medicine (Baltimore) | 2025 | 40988222 | PubTator, text mining | PubMed |
| Creation of a Novel Coding Program to Identify Genes Controlled by miRNAs During Human Rhinovirus Infection. | Methods Protoc | 2025 | 40981223 | PubTator, text mining | PubMed |
| Epigenome and transcriptome changes in KMT2D-related Kabuki syndrome Type 1 iPSCs, neuronal progenitors and cortical neurons. | PLoS Genet | 2025 | 40971994 | PubTator, text mining | PubMed |
| Multi-omics integration uncovers key transcriptional regulators in triple-negative breast cancer spatial heterogeneity. | Front Genet | 2025 | 40969325 | PubTator, text mining | PubMed |
| Extracting Clinical Guideline Information Using Two Large Language Models: Evaluation Study. | J Med Internet Res | 2025 | 40911841 | PubTator, text mining | PubMed |
| In silico multitargeted molecular docking study of interacting partners of epibrassinolide in cancer cells and in vitro evaluation of cell death mechanisms associated with these partners. | J Steroid Biochem Mol Biol | 2025 | 40858178 | PubTator, text mining | PubMed |
| Study on differentially expressed genes and pattern recognition receptors in osteoporosis based on bioinformatics analysis. | Sci Rep | 2025 | 40854963 | PubTator, text mining | PubMed |
| Identification and visualization of fusion gene subtypes in APL using spatial attention mechanisms in vision models. | Front Oncol | 2025 | 40809027 | PubTator, text mining | PubMed |
| Targeting RARγ Decreases Immunosuppressive Macrophage Polarization and Reduces Tumor Growth. | Molecules | 2025 | 40807274 | PubTator, text mining | PubMed |
| Functional Changes Associated With the Subcellular Localization of the Nuclear Receptor NR4A1. | Biochem Res Int | 2025 | 40746844 | PubTator, text mining | PubMed |
| Exploring Potential Therapeutic Applications of Tazarotene: Gene Regulation Mechanisms and Effects on Melanoma Cell Growth. | Curr Issues Mol Biol | 2025 | 40699636 | PubTator, text mining | PubMed |
| [A case of acute promyelocytic leukemia with NUP98::RARG::LINE-L2a tripartite fusion and the mechanism of resistance to all-trans retinoic acid]. | Zhonghua Yi Xue Za Zhi | 2025 | 40619972 | PubTator, text mining | PubMed |
| Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming. | Innovation (Camb) | 2025 | 40470327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5916/papers?page=3